首页> 外文期刊>Reproductive biomedicine online >Symposium: innovative techniques in human embryo viability assessment. Non-invasive assessment of embryo viability by metabolomic profiling of culture media ('metabolomics').
【24h】

Symposium: innovative techniques in human embryo viability assessment. Non-invasive assessment of embryo viability by metabolomic profiling of culture media ('metabolomics').

机译:研讨会:人类胚胎生存力评估的创新技术。通过培养基的代谢组学分析(“代谢组学”)对胚胎活力进行非侵入性评估。

获取原文
获取原文并翻译 | 示例
           

摘要

Increasing the efficiency of the IVF procedure by improving pregnancy/implantation rates and at the same time lowering (or avoiding) the risks of multiple gestations are the primary goals of the current assisted reproductive technology. These aims require a much improved gamete/embryo testing and selection procedure, which, using the current approach of microscopy-based morphology evaluation is unlikely to be achieved. Therefore, alternative or additional, non-invasive techniques have been proposed which may be able to detect alterations of the culture environment surrounding gametes/embryos reflective of the (patho-)physiological processes. One of the most recently applied approaches is to measure metabolomic changes in the culture medium of embryos and oocytes ('exometabolomics'). Initial studies have demonstrated that different types of spectrophotometric tests, including Raman and near-infrared (NIR) techniques, are similarly well capable of detecting specific changes of the 'secretome' (exometabolome). These studies have also demonstrated that metabolomic measurements correlate well with embryo development and morphology assessment. Furthermore, viability index on oocytes/embryos established by metabolomic tests may be a stronger predictor for implantation potential than traditional morphological assessment. Although the results of these initial investigations are promising, further prospective studies are required to define clearly the potential benefits and most relevant applications of this novel non-invasive technology in the field of assisted reproduction.
机译:当前的辅助生殖技术的主要目标是通过提高妊娠/着床率来提高试管婴儿的效率,同时降低(或避免)多次妊娠的风险。这些目标需要大大改进的配子/胚胎测试和选择程序,使用基于显微镜的当前形态学评估的当前方法不太可能实现。因此,已经提出了替代的或附加的非侵入性技术,其可能能够检测反映(病理)生理过程的配子/胚胎周围的培养环境的变化。最新应用的方法之一是测量胚胎和卵母细胞培养基中的代谢组学变化(“ exometabolomics”)。初步研究表明,不同类型的分光光度测试,包括拉曼和近红外(NIR)技术,同样能够检测“秘密组”(exometabolome)的特定变化。这些研究还表明,代谢组学测量与胚胎发育和形态学评估具有很好的相关性。此外,与传统的形态学评估相比,通过代谢组学测试建立的卵母细胞/胚胎的生存力指数可能是更强的植入潜能指标。尽管这些初步研究的结果令人鼓舞,但仍需要进行进一步的前瞻性研究,以明确界定这种新型非侵入性技术在辅助生殖领域的潜在益处和最相关的应用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号